Titre : | A nationwide survey of hepatitis C services provided by drug treatment programs |
Titre traduit : | (Enquête nationale sur les services de traitement de l'hépatite C fournis dans le cadre des programmes de traitement de l'usage de drogues) |
Auteurs : | S. M. STRAUSS ; G. P. FALKIN ; VASSILEV Z. ; D. C. DES JARLAIS ; J. ASTONE |
Type de document : | Périodique |
Année de publication : | 2002 |
Format : | 55-62 |
Note générale : |
Journal of Substance Abuse Treatment, 2002, 22, (2), 55-62 |
Langues: | Anglais |
Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
Mots-clés : |
Thésaurus mots-clés HEPATITE ; PREVENTION ; INFORMATION ; PROGRAMME ; TRAITEMENTThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug- free programs. (Editor's abstract.) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 43 |
Affiliation : |
Natl. Dev. Res. Inst., Inc., 71 West 23 st., 8th floor, New York, NY 10010. E-mail : strauss@ndri.org Etats-Unis. United States. |
Numéro Toxibase : | 403820 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil